Methyl-3β-hydroxycholenate

CAS No. 20231-57-6

Methyl-3β-hydroxycholenate( Methyl 3beta-hydroxychol-5-enoate )

Catalog No. M26287 CAS No. 20231-57-6

Methyl-3β-hydroxycholenate is a ROR gamma modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Methyl-3β-hydroxycholenate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl-3β-hydroxycholenate is a ROR gamma modulator.
  • Description
    Methyl-3β-hydroxycholenate is a ROR gamma modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Methyl 3beta-hydroxychol-5-enoate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    S. aureus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20231-57-6
  • Formula Weight
    388.592
  • Molecular Formula
    C25H40O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.S Wang, et al. Antibacterial activity and synergy of antibiotics with sanguisorbigenin isolated from Sanguisorba officinalis L. against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol. 2021 Mar;72(3):238-244.
molnova catalog
related products
  • Gnetifolin K

    Gnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.

  • IRE1α kinase-IN-1

    IRE1α kinase-IN-1 is a highly selective IRE1α (ERN1) inhibitor, with an IC50 of 77 nM. It displays 100-fold selectivity for IRE1α over the IRE1β isoform.

  • N6F11

    N6F11 is a novel, selective and potent inducer of ferroptosis with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells.